Lista de obras -

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

artículo científico publicado en 2021

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

artículo científico publicado en 2017

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

artículo científico publicado en 2008

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study

artículo científico publicado en 2016

Alzheimer's disease

artículo científico publicado en 2018

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

artículo científico publicado en 2014

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

artículo científico publicado en 2014

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

artículo científico publicado en 2018

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease

artículo científico publicado en 2016

Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition

artículo científico publicado en 2019

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

artículo científico publicado en 2019

Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

scientific article published on 01 March 2020

Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies

scientific article published on 24 March 2010

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

scientific article published on 17 September 2020

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.

artículo científico publicado en 2017

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease

artículo científico publicado en 2017

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.

artículo científico publicado en 2016

Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study

scientific article published on 31 March 2020

Clinical and genetic characteristics of late-onset Huntington's disease

artículo científico publicado en 2018

Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study

artículo científico publicado en 2019

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

artículo científico publicado en 2011

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

artículo científico publicado en 2021

Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

artículo científico publicado en 2020

Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years

scientific article published on 01 January 2019

Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years

artículo científico publicado en 2020

Detecting At-Risk Alzheimer's Disease Cases

artículo científico publicado en 2017

Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease

artículo científico publicado en 2008

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals

artículo científico publicado en 2016

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility

artículo científico publicado en 2015

Evidence for an association between KIBRA and late-onset Alzheimer's disease

artículo científico publicado en 2010

Factors influencing employment after minor stroke and NSTEMI

artículo científico publicado en 2020

Fine-mapping and candidate gene investigation within the PARK10 locus

artículo científico publicado en 2008

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

artículo científico publicado en 2019

Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimers disease risk

Genetic variation of Omi/HtrA2 and Parkinson's disease

artículo científico publicado en 2008

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility

artículo científico publicado en 2015

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

scholarly article by Iris E Jansen et al published March 2019 in Nature Genetics

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

artículo científico publicado en 2012

Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies

artículo científico publicado en 2006

Incidence of Young Onset Dementia in Central Norway: A Population-Based Study

scientific article published on 15 April 2020

LRRK2 mutations are not common in Alzheimer's disease

artículo científico publicado en 2005

LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).

artículo científico publicado en 2013

Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

artículo científico publicado en 2015

Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci

scientific article published in Scientific Reports

Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease

artículo científico publicado en 2010

Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer's Disease

artículo científico publicado en 2019

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease

artículo científico publicado en 2015

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions

artículo científico publicado en 2011

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study

artículo científico publicado en 2011

Risk-reducing effect of education in Alzheimer's disease

scientific article published on 01 November 2008

The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up

artículo científico publicado en 2020

The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study

artículo científico publicado en 2019

The development of cognitive and emotional impairment after a minor stroke: A longitudinal study

artículo científico publicado en 2019

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease

scholarly article by Daniel Twohig et al published 26 November 2018 in Acta neuropathologica communications

Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease

scientific article published on 01 October 2007

Lista de obras de

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study

Alzheimer's disease

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease

Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.

Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study

Clinical and genetic characteristics of late-onset Huntington's disease

Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years

Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years

Detecting At-Risk Alzheimer's Disease Cases

Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility

Evidence for an association between KIBRA and late-onset Alzheimer's disease

Factors influencing employment after minor stroke and NSTEMI

Fine-mapping and candidate gene investigation within the PARK10 locus

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimers disease risk

Genetic variation of Omi/HtrA2 and Parkinson's disease

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies

Incidence of Young Onset Dementia in Central Norway: A Population-Based Study

LRRK2 mutations are not common in Alzheimer's disease

LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).

Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci

Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease

Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer's Disease

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study

Risk-reducing effect of education in Alzheimer's disease

The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up

The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study

The development of cognitive and emotional impairment after a minor stroke: A longitudinal study

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease

Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease